Amgen Inc. Stock

Equity markets have handled the economic uncertainty and geopolitical instability we have seen in recent months admirably well so far. The S&P 500 is up 7% year to date. However, we may not be

The weight-loss market has become one of the most active therapeutic areas in the pharmaceutical industry over the past few years. And based on analyst projections, it will continue growing at a

Eli Lilly (NYSE: LLY) is the most valuable healthcare company in the world, with a market cap of around $950 billion. In the past five years, the stock price has soared an incredible 400%, thanks in

Broader equities almost always deliver positive returns over the span of a decade. That's been the case for over 100 years, other than a few 10-year periods that were rocked by significant economic

Last year was a rebound one for CVS Health (NYSE: CVS) and Amgen (NASDAQ: AMGN). After underperforming broader equities in 2024, both healthcare giants bounced back in 2025, outperforming the market

A volatile trading environment and high inflation should not deter investors from the stock market. These challenges will eventually subside, and equities have performed well over the long term

Earnings season always creates short-term winners and losers. Beverage behemoth Coca-Cola (NYSE: KO) and biotech giant Amgen (NASDAQ: AMGN) were firmly in the former category, as both delivered